This hypermethylation is similar to that observed in AML cells with mutant isocitrate dehydrogenase (IDH), where TET2 is inhibited by 2-hydroxyglutarate, the product of mutant IDH. This evidence concerns the gene TET2 and acute myeloid leukemia.